AstraZeneca's camizestrant and Pfizer's vepdegestrant extended progression-free survival in trials in advanced ESR1-mutated breast cancer.

On the eve of hurricane season, Florida’s top disaster official promised Floridians that they will see no changes to the state’s hurricane response despite the turmoil at Federal ...

New Orleans celebrated the repatriation and burial of the remains of 19 African American people whose skulls had been sent to Germany for racist research practices in the 19th century.

In May last year, the International Association of Anti-Corruption Authorities (IAACA), a 180-member-strong international anti-corruption organization currently headed by Danny Woo Ying-ming, ...

The Phase III trial showed that the new targeted therapy, inavolisib (Itovebi), provides significant survival benefits for ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced breast cancer, compared with palbociclib and fulve ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall ...

Detailed price information for Roche Holdings Ltd ADR (RHHBY) from The Globe and Mail including charting and trades.

Detailed price information for Roche Holdings Ltd ADR (RHHBY) from The Globe and Mail including charting and trades.

Roche (RHHBY) is planning to move a new antibiotic into late stage clinical trials after early studies showed it had ...

Autolus' CAR-T cell therapy for a rare and aggressive form of acute lymphoblastic leukaemia (ALL), Aucatzyl, has been ...